Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Organ xenotransplantation using human complement regulatory factor gene]

S Hayashi1, C Koike, K Isobe

  • 1Department of Surgery II, Nagoya University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Controlling hyperacute rejection is key for xenotransplantation success. Gene engineering with human complement regulatory factors in pigs shows promise for future organ donation, preventing immune system attacks.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Solid stress facilitates spheroid formation: potential involvement of hyaluronan.

British journal of cancer·2002
Same author

Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF.

Biochemical and biophysical research communications·2001
Same author

Comparison of the regulatory regions of the alpha1,3galactosyltransferase gene between murine and porcine species.

Transplantation proceedings·2001
Same author

Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha--> hypoxia response element--> VEGF cascade differentially regulates vascular response and growth rate in tumors.

Cancer research·2000
Same author

Isolation of the regulatory regions and genomic organization of the porcine alpha1,3-galactosyltransferase gene.

Transplantation·2000
Same author

Endogenous AP-1 levels necessary for oncogenic activity are higher than those sufficient to support normal growth.

Biochemical and biophysical research communications·2000

Area of Science:

  • Immunology and Transplantation Science
  • Genetic Engineering and Biotechnology